Wide variation in pre-procedural blood product transfusion practices in cirrhosis: a national multidisciplinary survey
- PMID: 37102761
- PMCID: PMC10146548
- DOI: 10.1097/HC9.0000000000000147
Wide variation in pre-procedural blood product transfusion practices in cirrhosis: a national multidisciplinary survey
Abstract
Background and aims: Recent guidelines recognize the limitations of standard coagulation tests in predicting bleeding and guiding pre-procedural blood component prophylaxis in cirrhosis. It is unclear whether these recommendations are reflected in clinical practice. We performed a nationwide survey to investigate pre-procedural transfusion practices and opinions of key health care stakeholders involved in managing cirrhosis.
Methods: We designed a 36-item multiple-choice questionnaire to investigate the international normalized ratio and platelet cutoffs utilized to guide pre-procedural transfusion of fresh frozen plasma and platelets in patients with cirrhosis undergoing a range of low and high-risk invasive procedures. Eighty medical colleagues from all mainland States involved in managing patients with cirrhosis were invited by email to participate.
Results: Overall, 48 specialists across Australia completed the questionnaire: 21 gastroenterologists, 22 radiologists, and 5 hepatobiliary surgeons. 50% of respondents reported that their main workplace did not have written guidelines relating to pre-procedural blood component prophylaxis in patients with cirrhosis. There was marked variation in routine prophylactic transfusion practices across institutions for the different procedures and international normalized ratio and platelet cutoffs. This variation was present both within and between specialty groups and held for both low and high-risk procedures. For scenarios where the platelet count was ≤ 50 × 109/L, 61% of respondents stated that prophylactic platelet transfusions would be given before low-risk and 62% before high-risk procedures at their center. For scenarios where the international normalized ratio was ≥2, 46% of respondents stated that prophylactic fresh frozen plasma would be routinely given before low-risk procedures and 74% before high-risk procedures.
Conclusion: Our survey reveals significant heterogeneity of pre-procedural prophylactic transfusion practices in patients with cirrhosis and discrepancies between guidelines and clinical practice.
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Association for the Study of Liver Diseases.
Conflict of interest statement
Amanda Nicoll advises and is on the speakers’ bureau for Eisai. She advises Roche and AstraZeneca and is on the speakers’ bureau for Ipsen. Jacob George advises and is on the speakers’ bureau for Pfizer. He advises AbbVie, AstraZeneca, and Gilead. He is on the speakers’ bureau for Roche. The remaining authors have no conflicts to report.
Figures



Similar articles
-
Prediction and prevention of post-procedural bleedings in patients with cirrhosis.Clin Mol Hepatol. 2025 Feb;31(Suppl):S205-S227. doi: 10.3350/cmh.2024.0928. Epub 2025 Feb 18. Clin Mol Hepatol. 2025. PMID: 39962975 Free PMC article. Review.
-
A multicenter study of the risk of major bleeding in patients with and without cirrhosis undergoing percutaneous liver procedures.Liver Transpl. 2025 Mar 1;31(3):269-276. doi: 10.1097/LVT.0000000000000447. Epub 2024 Aug 2. Liver Transpl. 2025. PMID: 39213304
-
Procedural bleeding risk, rather than conventional coagulation tests, predicts procedure related bleeding in cirrhosis.Eur J Gastroenterol Hepatol. 2022 Feb 1;34(2):192-199. doi: 10.1097/MEG.0000000000001948. Eur J Gastroenterol Hepatol. 2022. PMID: 32976185
-
A multicenter analysis of the role of prophylactic transfusion of blood products in patients with cirrhosis and esophageal varices undergoing endoscopic band ligation.JHEP Rep. 2021 Sep 16;3(6):100363. doi: 10.1016/j.jhepr.2021.100363. eCollection 2021 Dec. JHEP Rep. 2021. PMID: 34765959 Free PMC article.
-
AGA Clinical Practice Update: Coagulation in Cirrhosis.Gastroenterology. 2019 Jul;157(1):34-43.e1. doi: 10.1053/j.gastro.2019.03.070. Epub 2019 Apr 12. Gastroenterology. 2019. PMID: 30986390 Review.
Cited by
-
Rotational ThromboElastometry-guided blood component administration versus standard of care in patients with Cirrhosis and coagulopathy undergoing Invasive ProcEdures (RECIPE): study protocol for a randomised controlled trial.Trials. 2023 Aug 11;24(1):516. doi: 10.1186/s13063-023-07552-1. Trials. 2023. PMID: 37568228 Free PMC article.
-
Safety and Outcomes of an On-Demand Transfusion Strategy Versus Prophylactic Transfusion of Platelets in Patients With Liver Cirrhosis and Severe Thrombocytopenia Undergoing High-Risk Procedures: A Post Hoc Analysis of Two Randomized Controlled Trials.J Clin Exp Hepatol. 2025 May-Jun;15(3):102467. doi: 10.1016/j.jceh.2024.102467. Epub 2024 Nov 30. J Clin Exp Hepatol. 2025. PMID: 39822652
-
How to manage hemostasis in patients with liver disease during interventions.Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):274-280. doi: 10.1182/hematology.2023000480. Hematology Am Soc Hematol Educ Program. 2023. PMID: 38066857 Free PMC article. Review.
-
Prediction and prevention of post-procedural bleedings in patients with cirrhosis.Clin Mol Hepatol. 2025 Feb;31(Suppl):S205-S227. doi: 10.3350/cmh.2024.0928. Epub 2025 Feb 18. Clin Mol Hepatol. 2025. PMID: 39962975 Free PMC article. Review.
-
Does the Use of Viscoelastic Hemostatic Assays for Periprocedural Hemostasis Management in Liver Disease Improve Clinical Outcomes?Transfus Med Rev. 2024 Jul;38(3):150823. doi: 10.1016/j.tmrv.2024.150823. Epub 2024 Mar 19. Transfus Med Rev. 2024. PMID: 38616454 Free PMC article. Review.
References
-
- Segal JB, Dzik WH. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion. 2005;45:1413–1425. - PubMed
-
- Janko N, Majeed A, Commins I, Kemp W, Roberts SK. Procedural bleeding risk, rather than conventional coagulation tests, predicts procedure related bleeding in cirrhosis. Eur J Gastroenterol Hepatol. 2022;34(2):192–199. - PubMed
-
- Napolitano G, Iacobellis A, Merla A, Niro G, Valvano MR, Terracciano F, et al. . Bleeding after invasive procedures is rare and unpredicted by platelet counts in cirrhotic patients with thrombocytopenia. Eur J Intern Med. 2017;38:79–82. - PubMed
-
- Basili S, Raparelli V, Napoleone L, Talerico G, Corazza GR, Perticone F, et al. . Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: results from the PRO-LIVER Study. Am J Gastroenterol. 2018;113:368–375. - PubMed
-
- Kovalic AJ, Majeed CN, Samji NS, Thuluvath PJ, Satapathy SK. Systematic review with meta-analysis: abnormalities in the international normalised ratio do not correlate with periprocedural bleeding events among patients with cirrhosis. Alimentary Pharmacol Ther. 2020;52:1298–1310. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical